Companies attempting to tackle the global obesity epidemic will become part of a much larger investment trend in the next 25 years or more.

According to a Bank of America Merrill Lynch Global Research report, "Globesity—The Global Fight Against Obesity," there are more than 50 companies out there focused on pharmaceuticals and healthcare, food, commercial weight loss, diet management and nutrition and sports apparel and equipment that will dominate the stock markets in the near future.

"Global obesity is a mega-investment theme for the next 25 years and beyond. Obesity may be the most pressing health challenge facing the world today and efforts to tackle it will shape thinking by policy makers and in boardrooms around the world," said Sarbjit Nahal, equity strategist at BofA Merrill Lynch Global Research.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.